本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Alpha Tau Medical

2.70
+0.05502.08%
成交量:6,873.00
成交額:1.85萬
市值:1.90億
市盈率:-5.94
高:2.70
開:2.67
低:2.67
收:2.64
資料載入中...
2025/03/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/12

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/20

SEC問詢函

Form CORRESP - Correspondence
2023/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/04/11

SEC問詢函

CORRESP [Cover] - Correspondence
2023/03/23

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/09

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/05/18

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/03

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/03

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers